logo

HELP

CybinยทNASDAQ
--
--(--)
--
--(--)

HELP Profile

Cybin Inc.

Deuteration Technology Breaks Through in Mental Health! Cybin Secures FDA Breakthrough Therapy Designation, Approaching Key Milestone in Phase III Trials

Pharmaceutical
10/13/2016
01/05/2026
NASDAQ Stock Exchange
50
03-31
Common stock
100 King Street West, Suite 5600, Toronto, Ontario, Canada M5X 1C9
--
Cybin Inc., was founded on October 13, 2016 in Ontario, Canada. The company operates in Canada, the United States, the United Kingdom and Ireland. The company focuses on developing psychedelics into therapies by designing patented drug discovery platforms, innovative drug delivery systems, novel formulation methods and treatment options for mental health disorders.